|
Single-cell Sequencing 靶向单细胞测序（lncRNA&mRNA） 单细胞测序 |
| DIA定量蛋白质组学 Label free非标定量 |
Protein Modification Quantification N-糖基化蛋白组学 O-GlcNAc修饰蛋白质组学 |
|
Ribo-seq Ribo seq（ribosome profiling） |
RNC RNC联合 circRNA芯片 RNC联合 lncRNA芯片 RNC-seq |
|
Next gene Sequencing 环状DNA测序（eccDNA测序） |
PCR 环状DNA PCR技术服务 |
Shu Pu (Shanghai) Biotechnologies LLC (DBA Aksomics) is a premier high-tech enterprise specializing in cutting-edge technical services for life science research. We are dedicated to providing innovative solutions for life sciences and medical research, offering a comprehensive suite of services that includes microarray analysis, single-cell sequencing, next-generation sequencing (NGS), immunoprecipitation sequencing, and mass spectrometry.
Building on over two decades of industry expertise, Aksomics has established a robust, one-stop technology platform. Our core competencies lie in epitranscriptomics and non-coding RNAs—particularly tRNAs, tRFs, and other small RNAs. This is complemented by our extensive capabilities in RNA glycosylation, G-quadruplexes (G4) and R-loops, epigenomics, DNA/RNA/protein interactions, and proteomics.
Headquartered in Shanghai with multiple branch offices across China, Aksomics shares strategic resources with its partner, Shanghai Kangcheng Bioengineering Co., Ltd. As the exclusive distributor for Arraystar Inc. (USA) in China, our Life Science Experiment Center is equipped with state-of-the-art instrumentation. Supported by an experienced experimental team and a highly proficient bioinformatics group, we deliver reliable data, premium products, and expert technical support to drive scientific innovation.
To date, Aksomics has forged long-term, strategic collaborations with top-tier research institutes and medical centers across China. These include the Chinese Academy of Sciences, Peking University Health Science Center, Sun Yat-sen University School of Medicine, and the affiliated hospitals of Shanghai Jiao Tong University (Ruijin Hospital), Fudan University (Zhongshan Hospital), and Huazhong University of Science and Technology (Union Hospital).
We take pride in empowering our clients to publish breakthrough discoveries in world-renowned journals, including Cell, Nature Medicine, Nature Genetics, Nature Immunology, Cancer Cell, Molecular Cell, Circulation, and Hepatology. In the field of non-coding RNA alone, our technical services have supported the publication of over 2,300 SCI papers with a cumulative impact factor (IF) exceeding 10,000. This includes over 500 papers in the small RNA field, featuring two publications with an IF > 50 and eight with an IF > 30. In epigenetics, our clients have published over 240 SCI papers (cumulative IF > 2,700), including ten with an IF > 25. Across all our technology platforms, Aksomics has proudly supported the publication of over 3,200 SCI papers, achieving a staggering cumulative impact factor of more than 17,200.
Services
R-loop Epitranscriptomics Epigenomics Transcriptomics Proteins Single-cell Sequencing Proteomics translatomics eccDNA ExosomicsProducts
Arraystar Products Kangchen ProductsResources
News Customer Publications Customer Article Analysis Reviews Promotions Product ManualCompany
About Us Careers Login Contact Us
